ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Repayments of term debt

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndRepayments of term debt (Million USD)YoY (%)
Dec 31, 202148-96.40%
Dec 31, 20201,333-61.26%
Dec 31, 20193,441-72.32%
Dec 31, 201812,433+43.73%
Dec 31, 20178,650+71983.33%
Dec 31, 201612-78.95%
Dec 31, 201557-81.19%
Dec 31, 2013303-89.94%
Dec 31, 20113,012+79.95%
Dec 31, 20101,674

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat